BWL
TXMD icon

Bogart Wealth LLC’s TherapeuticsMD TXMD Stock Holding History

Bogart Wealth LLC’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Buy
+2
New +$4 ﹤0.01% 1814

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bogart Wealth LLC's TXMD Position: Q1 2026 in Review

Bogart Wealth LLC opened a new position in TherapeuticsMD (TXMD) in Q1 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #1814 among its holdings.

49 funds tracked by Wall St. Rank hold TXMD as of Q1 2026.

  • Bogart Wealth LLC held 2 shares of TherapeuticsMD worth $4 as of Q1 2026.
  • TherapeuticsMD was a new Bogart Wealth LLC position in Q1 2026.
  • TherapeuticsMD made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q1 2026, its #1814 holding.
  • 49 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2026.

Based on Bogart Wealth LLC's 13F filing for Q1 2026, filed 28 Apr 2026.